Ophthalmological screening guidelines for individuals with Osteogenesis Imperfecta: a scoping review.

Background: Osteogenesis imperfecta (OI) is a connective tissue disorder in which the Type 1 collagen is defective. The eye is a structure rich in collagen Type 1 and is heavily impacted by the disease. Many vision-threatening eye diseases have been associated with OI.